Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces that it has closed the first tranche of its previously announced non-brokered private placement ("Offering") of units (the "Units").

The Company issued a total of 4,185,500 Units at a price of $0.50 per Unit for gross proceeds...